BioVie Inc. Sets Up Up to $6.46 Million At-the-Market Share Sale Program
BioVie entered a sales agreement with A.G.P./Alliance Global Partners allowing it to sell up to $6,464,341 of Class A common stock through the agent over time. The company pays the agent a 3.0% commission on gross proceeds and says it may use proceeds for general corporate purposes; it has no obligation to sell any shares. Shareholders may face dilution if the shares are sold.
Key points
- Aggregate offering price of up to $6,464,341 in Placement Shares under the Sales Agreement dated September 11, 2026
- Agent commission of 3.0% of gross proceeds, plus reimbursement of certain specified expenses
- Sales made under Form S-3 (File No. 333-296924), declared effective June 29, 2026; offering ends no later than the registration statement's third anniversary
- Company has no obligation to sell shares and may suspend or terminate the offering at any time
The filing
Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 11, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.